Taizhou Suntrine Biotechnology Co., Ltd. ("Suntrine Biotechnology") is a high-tech enterprise specializing in production, manufacturing and sales of Biopharmaceutical polymer consumables. The company focuses on the IVD and Biopharmaceutical polymer consumables field, focuses on the life science field, and continuously introduces products that meet the diverse needs of customers and the industry through independent research and development. The application fields of the product line cover: molecular biology, cell biology, immune cell therapy, genetic engineering drug research and development, cell engineering drug research and development, drug screening, vaccine research and development, genomics, proteomics, CDMO and other life science fields, Situated adjacent to China Medical City in Gaogang District,Taizhou, Jiangsu Province, SUNTRINE's production base covers an area of 15,000 square meters, including 5,000 square meters of class 100,000 clean rooms;SUNTRINE runs PCR labs, chemical labs and microbiological labs, having exported its products to 32 countries including the United States, Germany and Russia.SUNTRINE passed the national high-tech certification and was rated as an Up-to-standard Organization of Jiangsu Province in Quality Safety, a Three-star On-cloud Enterprise of Jiangsu Province, an Intellectual Property Standard Implementation Organization of Jiangsu Province, a Gazelle Enterprise in Taizhou, and an Industrialization-informatization Integrated Enterprise.
Consumables
Here is an opportunlty to contact and meet other potentlal companles or partners.
If you are interested in booking a stand at CACLP, please leave your details below and one of our representatives will be in touch soon.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.